piyasalar Çarşamba, 06 Mayıs 2026 0,00

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance basliginda one cikan gelisme: Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.

Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.

Orijinal kaynak: CNBC

Paylaş: